Wilber Su, M.D., chief of cardiac electrophysiology,...
Ablation Systems
This channel provides technology news on new ablation system advances in cardiac electrophysiology (EP) used to treat dysfunctional heart tissue that cause arrhythmias. Each cell in the myocardium generates its own electrical impulses to cause the heart to beat, but if some cells generate signals that are not in synch with other parts of the heart, it causes an arrhythmia, an abnormal heart beat. Ablation systems use heat (usually generated by radio frequency, RF, energy or a laser) or extreme cold to cause small burns. These lesions create scar tissue that block electrical signals causing the arrhythmia. These procedures are guided by EP electro mapping systems.
-
-
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held company developing a single-shot cryoablation platform for the treatment of...
-
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in catheter ablation procedures for cardiac arrhythmias, for $292 million Euros.
-
May 25, 2018 — Data from the first-in-human study using pulsed electric field (PEF) energy ablate heart tissue in the treatment atrial fibrillation shows very positive evidence and may usher in a...
A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters. Researchers raised the question whether an economic benefit should be assessed in FDA reviews.
Feature | Cardiovascular Business | January 14, 2019 | Philip Jacobs, DPhil, Ilke Akpinar, M.D., Thanh Nguyen, M.D., Ph.D., Rupinder Sandhu, M.D., and Lars Thording Ph.D.
In an age when everything in medicine is now looked at though a cost vs. benefit analysis and U.S. government...
Navik 3D Cardiac Mapping System image courtesy of APN Health.
News | EP Lab | December 10, 2018
December 10, 2018 — Electrophysiology,...
News | Ablation Systems | November 30, 2018
November 30, 2018 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has...
News | EP Mapping and Imaging Systems | October 29, 2018
October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto...
Technology | Ablation Systems | October 09, 2018
October 9, 2018 — Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA)...
News | Ablation Systems | August 28, 2018
August 28, 2018 — Medtronic plc announced new findings from the CRYO4PERSISTENT AF...
News | Ablation Systems | August 02, 2018
August 2, 2018 — Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its...
News | Ablation Systems | July 13, 2018
July 13, 2018 — Boston Scientific Corp. recently announced a definitive agreement to...
A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.
News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in...
Figure 1: Images showing the effect of both surgical epicardial PEF ablation and catheter based PEF ablation in the first-in-human electroporation ablation study to freat Afib.
News | May 25, 2018
May 25, 2018 — Data from the first-in-human study using pulsed electric field (PEF) energy ablate heart tissue in...
News | Ablation Systems | May 22, 2018
May 22, 2018 — LuxCath LLC showcased the next generation of its proprietary OmniView light-guided...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.
News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-...
